Your healthcare provider's expectations on whether a treatment works may impact its effectiveness

If a doctor expects a treatment to be successful, a patient may experience less pain and have better outcomes, according to a new study. The findings reveal how social interactions between hypothetical healthcare providers and patients have the power to influence how patients perceive the effectiveness of a treatment, even when it is a placebo.

Read more

New effective vaccines for Lyme disease are coming

There is no effective vaccine currently available to prevent Lyme disease in humans. Experts from academia, government, and industry recently convened to tackle this public health challenge. Now, a new article reiterates the need to stop the infection, and defines a strategy for developing effective vaccines.

Read more

Scientists work toward a rapid point-of-care diagnostic test for Lyme disease

A study describes a new rapid assay for Lyme disease that could lead to a practical test for use by healthcare providers. The researchers found the assay, which uses several biomarkers to detect Lyme disease infection, was more sensitive than current laboratory-based tests when diagnosing Lyme disease early after suspected infection.

Read more

Hope for millions of IBS sufferers as research identifies cause of pain as 'gut itch'

This is big news for irritable bowel syndrome (IBS) patients: 11% of the world's population suffers from IBS, but the fight against chronic pain has taken a major step forward with scientists identifying receptors in the nervous system which cause the condition in the hope of developing effective treatments.

Read more

New study may have the reason why heart medication gives muscle pain

A research team found muscle cells treated with statins released the amino acid called glutamate at much higher levels than muscle cells that were untreated. As glutamate is a potent activator of muscle pain receptors, this release was proposed to trigger the sensation of muscle pain.

Read more

New test diagnoses Lyme disease within 15 minutes

Current testing for Lyme disease, called the standard 2-tiered approach or the STT, involves running two complex assays (ELISA and western blot) to detect antibodies against the bacterium, and requires experienced personnel in a lab, and a few hours to carry out and interpret. Biomedical engineers have developed a rapid microfluidic test that can detect Lyme disease with similar performance as the STT in a much shorter time — 15 minutes.

Read more